weight gain after stopping tirzepatide Rebound (Mounjaro or Zepbound) Stopping Tirzepatide Led to Weight
Description
Dipeptidyl peptidase 4 inhibitors are now widely used in the treatment of patients with type 2 diabetes mellitus

GLP-1 treatment that reduces appetite and helps control cravings

Eli Lilly and Company has registered its intent to carry out a Phase 3b clinical trial that will see the companys tirzepatide (Mounjaro) compared with Novo Nordisks semaglutide (Wegovy) 2.4mg in 700 adult participants who have obesity or overweight with weight related comorbidities without Type 2 diabetes

Titration, results, side effects

Provider-reviewed, prescription-only

Dietlicious Health Blog
